Medication info
Cozartan-X Tablet 5/50 mg (Amlodipine, Losartan Potassium)

Cozartan-X Tablet 5/50 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle. 300 tablets/bottle
Approval status
Active

MFDS item code 201502670 · Approved 2015.04.30 · Insurance code 661904520

Summary

Main use
Essential hypertension; initial treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment goal compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular effective circulating volume: Administration of this medicine is not recommended in a small number of patients with reduced intravascular effective circulating volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, a starting dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its administration is not recommended.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Essential hypertension; initial treatment of stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension who have difficulty controlling blood pressure with either amlodipine or losartan monotherapy. It is particularly prescribed as initial therapy when combination therapy is required to achieve treatment target blood pressure in patients with stage 2 hypertension. These drugs help effectively lower blood pressure and reduce the risk of cardiovascular diseases.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected extent to which the combination product will achieve the treatment goal compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular effective circulating volume: Administration of this medicine is not recommended in a small number of patients with reduced intravascular effective circulating volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, a starting dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its administration is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. There may also be risks to the fetus in early pregnancy, so women who may become pregnant should avoid taking this medication. Patients with low blood volume or those taking diuretics should manage their condition well prior to taking this medication, as there may be a risk of a sudden drop in blood pressure. Patients with allergies to any of its components or severe liver or heart disease should avoid taking this medication. Elderly patients or those with renal impairment may require dosage adjustments and should take it cautiously after consulting a healthcare professional. Dizziness or drowsiness may occur during usage, so it is advisable to avoid driving or operating hazardous machinery. For patients taking other antihypertensive medications or potassium-sparing diuretics, the blood pressure-lowering effect may become excessive, so it is important to inform the healthcare professional about current medications. This medication should not be administered during breastfeeding, and its safety has not been established in children, so its use is not recommended. Taking an overdose may lead to severe hypotension and heart problems, so it is essential to adhere strictly to the dosage, and if unusual symptoms occur, a healthcare facility should be visited immediately. This medication should be stored out of reach of children, and it is advisable not to transfer it to other containers.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
Show 162 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • frequent urination
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • vomiting
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension increase
  • sensory decrease
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinus block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • skin flushing
  • maculopapular rash
  • heavy-headedness
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • bloating
  • loss of appetite
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • neuroexcitability
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • pulmonary congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • sweating
  • erythroderma
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased visual acuity
  • nocturia
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • abnormal liver function
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • elevated serum creatinine
  • decreased blood pressure
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactoid syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a well-closed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. This will help preserve the medication's effectiveness.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle. 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.